Valuation: LifeVantage Corporation

Market Cap 74.54M 66.42M 61.49M 55.65M 105M 7.03B 106M 737M 289M 3.7B 280M 274M 11.78B P/E 2027 *
30.5x
P/E 2028 * 18.9x
Enterprise Value 61.85M 55.12M 51.03M 46.18M 87.01M 5.84B 88.04M 612M 240M 3.07B 232M 227M 9.78B EV / Sales 2027 *
0.37x
EV / Sales 2028 * 0.36x
Free-Float
86.31%
Yield 2027 *
-
Yield 2028 * -
1 day-0.34%
1 week+2.59%
Current month-5.56%
1 month-4.34%
3 months-7.03%
6 months+21.18%
Current year-3.41%
1 week 5.93
Extreme 5.9324
6.2
1 month 5.3
Extreme 5.295
6.42
Current year 3.9
Extreme 3.9
11.71
1 year 3.9
Extreme 3.9
11.71
3 years 3.9
Extreme 3.9
27.38
5 years 3.04
Extreme 3.04
27.38
10 years 2.86
Extreme 2.86
27.38
Manager TitleAgeSince
Chief Executive Officer 63 04/08/2026
Director of Finance/CFO 53 24/10/2021
Chief Tech/Sci/R&D Officer - 06/01/2026
Director TitleAgeSince
Director/Board Member 74 31/12/2011
Director/Board Member 67 31/01/2017
Director/Board Member 68 16/02/2022
Date Insider Type Main position Quantity % Market Cap. Importance
07/10/26 Free

Chief Financial Officer

89,372 0.7099%
07/10/26 Free

Responsable ventes & marketing

82,125 0.6523%
07/10/26 Free

Chief Executive Officer

483,092 3.8373%
Change 5-day change 1-year change 3-year change Capi.($)
-0.34%+2.59%-31.05%-16.20% 74.54M
-1.01%+5.13%+58.93%+117.36% 1,133B
-0.61%+1.52%+34.34%+68.48% 621B
-1.48%+0.47%+23.08%+94.76% 503B
-1.26%+1.98%+38.04%+63.00% 379B
+1.07%+1.70%+71.06%+45.98% 370B
+0.69%+1.54%+21.91%+51.29% 292B
+0.15%-0.58%+0.67%+24.99% 262B
-0.14%+2.87%+45.56%+57.22% 237B
-1.88%+0.02%+23.77%+97.39% 190B
Average +0.02%+3.15%+28.63%+60.43% 398.81B
Weighted average by Cap. +0.36%+3.73%+40.70%+79.66%

Financials

2027 *2028 *
Net sales 165M 147M 137M 124M 233M 15.61B 235M 1.64B 642M 8.21B 621M 608M 26.15B 168M 149M 138M 125M 236M 15.82B 239M 1.66B 651M 8.32B 629M 616M 26.5B
Net income 2.49M 2.22M 2.05M 1.86M 3.5M 235M 3.54M 24.62M 9.66M 123M 9.34M 9.14M 393M 4M 3.56M 3.3M 2.98M 5.62M 377M 5.69M 39.53M 15.51M 198M 14.99M 14.68M 632M
Net Debt -12.68M -11.3M -10.46M -9.47M -17.84M -1.2B -18.05M -125M -49.23M -629M -47.58M -46.59M -2B -14.88M -13.26M -12.28M -11.11M -20.93M -1.4B -21.18M -147M -57.75M -738M -55.82M -54.65M -2.35B
Projected Income Statement - Annual - LifeVantage Corporation
Logo LifeVantage Corporation
LifeVantage Corporation is an activation company, which is engage in the identification, research, development, formulation and sale of advanced nutrigenomic activators, dietary supplements, weight management products, pre- and pro-biotics, skin and hair care products, and nootropics. The Company’s line of scientifically validated activators includes the flagship Protandim family of products, TrueScience Liquid Collagen, the newest MindBody GLP-1 System, Activation-supporting nutrients such as Omega, D3+, and the Rise AM & Reset PM System , as well as AXIO nootropic energy drink mixes, the full TrueScience line of skin and hair care products, and Petandim, a pet supplement formulated to combat oxidative stress in dogs. It sells its products in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand and Singapore.
Employees
216
Date Price Change Volume
21/10/26 US$5.950 -0.34% 30,297
20/10/26 US$5.970 -0.17% 22,805
19/10/26 US$5.980 -0.33% 26,981
16/10/26 US$6.000 0.00% 14,640
15/10/26 US$6.000 +3.45% 41,070
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - LifeVantage Corporation
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
5.950USD
Average target price
7.500USD
Spread / Average Target
+26.05%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - LifeVantage Corporation
  1. Stock Market
  2. Stocks
  3. LFVN Stock